Next-generation sequencing revealed that these lesions harbored a common somatic mutation in epidermal growth factor receptor (<i>EGFR</i>), c.3617A>C, which is not considered a pathogenic chordoma mutation, thus indicating that these lesions were not multicentric but rather multiple metastatic tumors. This evidence concerns the gene EGFR and metastatic neoplasm.